LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. MetLife Inc (MET) insiders filed no open-market purchases or sales in the 90 days to Oct 18, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a MET trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Gotham Asset
$10.5M
added
Sells/Trims (2)
Qube Research
$91.2M
trimmed
Millennium
$62.6M
trimmed
Sells (1)
Debel Marlene
$1.7M
sold
Trader 684Long
$16K
position
Trader FFFLong
$14K
position
Last report
Aug 5, 2026
Period ending
Jun 30, 2026
Adjusted EPS
$2.29 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $2.43 / $2.29Yahoo Finance | +6.16% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 6, 2026 | $2.42 / $2.27Yahoo Finance | +6.65% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $2.49 / $2.34Yahoo Finance | +6.30% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 5, 2025 | $2.37 / $2.32Yahoo Finance | +2.16% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 6, 2025 | $2.02 / $2.16Alpha Vantage | -6.48% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $1.96 / $2.01Alpha Vantage | -2.49% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 5, 2025 | $2.09 / $2.09Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $1.95 / $2.18Alpha Vantage | -10.55% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$2.50 to $2.92
Revenue expected
7 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $16.88B | $23.81B | $19.07B | $18.88B |
| Cost of what it sold | $13.94B | $16.54B | $11.97B | $16.09B |
| Gross profit | $2.94B | $7.27B | $7.10B | $2.79B |
| What it spent | ||||
| Sales and admin | $1.53B | $3.73B | $1.70B | $1.69B |
| Other operating costs | $198.0M | $2.42B | $3.90B | $65.0M |
| Total operating expenses | $1.73B | $6.15B | $5.60B | $1.75B |
| What was left | ||||
| Operating profit | $1.21B | $1.12B | $1.51B | $1.03B |
| Interest on debt | $271.0M | $263.0M | $265.0M | $292.0M |
| Profit before tax | $1.21B | $1.12B | $1.51B | $1.03B |
| Tax | $308.0M | $301.0M | $345.0M | $256.0M |
| Net profit | $896.0M | $809.0M | $1.19B | $736.0M |
| EBITDA | $1.48B | $1.38B | $1.77B | $1.33B |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Can The Hartford's Equitable Deal Strengthen Its Benefits Business?
Leans bullishOct 14Bank of America sets USD 119 target for MetLife stock
BullishOct 143 U.S. Life Insurance Stocks To Watch If Higher Rates Hold
NeutralOct 14MetLife integrates pet insurance with ChatGPT plugin By Investing.com
BullishOct 14MetLife stock pre-market at EUR 90.01
NeutralOct 14MetLife stock after-hours at EUR 89.85 on October 13, 2026
NeutralOct 13Metlife stock reaches all-time high at 101.0 USD
BullishOct 13MetLife (NYSE:MET) Hits New 52-Week High Following Analyst Upgrade
NeutralOct 13